Doug Sandler, of the Riverfront Investment Group, thinks biotech is set to go higher after earnings season and could be an investor’s chance to play catch-up. Doug draws a correlation between biotech and the technology sector. With the recent run in Read more…

IBB, NYSE:BBH, NYSE:FBT, PBE, XBI

“Each week, I like to publish the past week’s hottest ETFs to share some new trends and niche ETFs out there and give investors some new ideas. For this week, Tech finally took a break (if you can call a 10% gain on TYH a “break”) in comparison to some of the other leveraged ETFs. Read more…

ETF BASIC NEWS, NYSE:FBT, TAN, TYH, UMM